Has Amber Ewonce, OD received payments from drug or device companies?

Yes. Drug and device makers reported $3,753 in general payments to Amber Ewonce, OD across 87 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amber Ewonce, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amber Ewonce, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amber Ewonce, OD

Optometrist · Coraopolis, PANPI 1902420961

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,468 of the $3,753 with a category attached, or 65.8%. 18 manufacturers reported payments, led by Coopervision Inc. at 41.3% of the total. Reporting peaked in 2023 at $1,800 and has fallen 76.1% since, to $430 in 2025. Among optometrist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,753in general payments, 2019–2025

Across 87 payments — averaging $43.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coopervision Inc.$2K
Alcon$373
Bausch & Lomb Americas Inc.$318
Johnson & Johnson Vision Care, Inc.$301
Tarsus Pharmaceuticals, Inc.$201
AbbVie$189
plus $821 from 12 others

What the payments were for

Speaking & faculty fees$1,28534%
Food & beverage$2,46866%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coopervision Inc.	11	$1,549
Alcon	12	$373
Bausch & Lomb Americas Inc.	15	$318
Johnson & Johnson Vision Care, Inc.	15	$301
Tarsus Pharmaceuticals, Inc.	5	$201
AbbVie(2 entities)	5	$189
Amgen	2	$137
Apellis Pharmaceuticals, Inc.	1	$114
Glaukos Corporation	1	$113
Sun Pharmaceutical Industries Inc.	5	$98
LKC Technologies, Inc.	2	$85
Novartis	4	$77
Harrow Eye, LLC	2	$50
Dompe US, Inc.	2	$45
Kala Pharmaceuticals, Inc.	2	$40
Thea Pharma Inc.	1	$23
Oyster Point Pharma, Inc.	1	$21
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,753 in reported general payments places this provider in the 90th percentile of 2,165 optometrist providers in Pennsylvania.

See all optometrist providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$17,025

Medicare patients

111

Services billed

199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone	27	$1,466
Prednisolone Acetate	16	$875
Latanoprost	52	$511

Paid to pharmacies, not to this prescriber.

Other optometrist in Coraopolis

Noah EgerCoraopolis$18K
James DeomHazle Township$793K
Gregory CaldwellDuncansville$547K
Leslie O DellNew Freedom$388K
Kevin BistlinePlymouth Meeting$302K
Thomas KislanStroudsburg$266K
Erick HendersonPittsburgh$266K
Ryan YealyLancaster$164K
Joseph SmayNew Kensington$147K
Julie McLaughlinAllentown$142K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →